Insider Holders & Insider Ownership - Altimmune Inc. (ALT)

List of insiders holdings for Altimmune Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
EVNIN LUKE
GALAKATOS NICHOLAS
HENNER DENNIS
STEINMETZ MICHAEL
GADICKE ANSBERT
WHEELER KURT
SIMON NICHOLAS J III
10% Owner
2010-11-05 15:59:590
6,347,614
6,347,614Form 4
PRESCOTT GROUP CAPITAL MANAGEMENT L.L.C.
FROHLICH PHIL
10% Owner
2017-02-10 16:07:093,262,422
0
3,262,422Form 13G
VELOCITY PHARMACEUTICAL HOLDINGS LLC
10% Owner
2021-02-16 16:23:131,938,335
0
1,938,335Form 13G
VELOCITY PHARMACEUTICAL HOLDINGS LLC
Collier David J
Watson James F
Velocity Pharma Management LLC
10% Owner
2021-02-16 16:23:131,938,335
0
1,938,335Form 13G
Venrock Healthcare Capital Partners III L.P.
VHCP Co-Investment Holdings III LLC
VHCP Management III LLC
Venrock Healthcare Capital Partners II L.P.
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
Koh Bong Y
Shah Nimish P
10% Owner
2022-02-14 16:20:461,760,870
0
1,760,870Form 13G
Truffle Capital S.A.S.
10% Owner
2018-02-15 16:49:370
1,537,442
1,537,442Form 4
RICHMAN ERIC I
Director
2016-11-23 16:46:05898,055
10,000
908,055Form 4
KINLEY MATTHEW P
Former President & Treasurer
2007-08-16 19:40:58611,980
0
611,980Form 4/A
SCHAFFER DERACE L
Director
2018-01-02 17:09:50589,453
12,393
601,846Form 4
Hodges Philip
Redmont VAXN Capital Holdings LLC
Redmont Venture Partners Inc.
Paradigm Venture Partners L.P.
Director
2017-10-19 17:21:06583,691
0
583,691Form 13D
Hodges Philip
Redmont VAXN Capital Holdings LLC
Director
2017-10-19 17:21:06583,691
0
583,691Form 13D
WRIGHT DAVID P
President and CEO
2009-12-14 12:49:09399,500
0
399,500Form 4
Enright William
President and CEO
2018-05-29 18:17:36365,839
0
365,839Form 4
HEALTHCARE VENTURES VII LP
LAWLOR AUGUSTINE
LITTLECHILD JOHN W
Mirabelli Christopher
WERNER HAROLD R
CAVANAUGH JAMES H
HealthCare Partners VII L.P.
10% Owner
2011-10-05 16:45:07358,814
0
358,814Form 13G
HEALTHCARE VENTURES VII LP
HealthCare Partners VII L.P.
CAVANAUGH JAMES H
LITTLECHILD JOHN W
WERNER HAROLD R
LAWLOR AUGUSTINE
Mirabelli Christopher
AGUIAR ERIC
10% Owner
2011-10-05 16:45:07358,814
0
358,814Form 13G
Garg Vipin K
President and CEO
2024-02-05 18:00:45346,473
0
346,473Form 4
Novartis Bioventures Ltd
NOVARTIS AG
10% Owner
2019-02-05 16:05:59309,216
0
309,216Form 13G
WEAVER GREGORY L
Chief Financial Officer
2024-11-12 16:50:52300,000
0
300,000Form 4
St Peter Steven
Director
2017-01-05 16:31:04205,004
0
205,004Form 4
Runge Jeffrey W.
Director
2017-01-24 16:30:35197,700
0
197,700Form 4
Cook Francesca M
SVP, Policy & Gov't Affairs
2014-12-10 20:59:59171,582
0
171,582Form 4
MORGES WAYNE
SVP, Reg. Affairs & Quality
2014-12-10 21:01:44167,096
0
167,096Form 4
Price Kevin
President - PharmAthene UK,Ltd
2009-02-10 17:07:34166,900
0
166,900Form 4
MACNEILL PHILIP
VP, CFO, Treasurer, Secretary
2016-12-22 16:15:33166,658
0
166,658Form 4
MILLENCO L.L.C.
MILLENNIUM MANAGEMENT L.L.C.
ENGLANDER ISRAEL A
10% Owner
2024-10-16 16:21:16144,153
0
144,153Form 13G
CZEREPAK ELIZABETH
CFO and EVP Corp. Development
2017-09-26 18:36:33125,000
0
125,000Form 4
Jones Jeffrey Michael
COO
2015-03-27 16:58:44123,680
0
123,680Form 3
FUERST THOMAS RICHARD
EVP, Chief Scientific Officer
2011-12-05 20:21:44104,545
0
104,545Form 4
Riddle Valerie D
SVP, Medical Director
2011-06-01 21:12:4379,380
0
79,380Form 4
CHANG LINDA L
SVP, CFO & Secretary
2015-01-09 19:00:2475,400
0
75,400Form 4
Reinhart Charles A. III
SVP, Chief Financial Officer
2010-12-10 17:09:4475,000
0
75,000Form 4
Eisenstadt Richard I
Chief Financial Officer
2024-02-01 18:00:1672,837
0
72,837Form 4
Karp Jordan P
SVP, General Counsel
2012-12-05 19:24:2565,000
0
65,000Form 4
Drutz David
Director
2024-08-20 18:05:084,350
55,524
59,874Form 4
Harris Matthew Scott
Chief Medical Officer
2024-08-01 17:40:4155,119
0
55,119Form 4
Camut Christopher C
VP, Gov't Contracts
2010-01-29 14:55:2446,777
0
46,777Form 4
Roberts M Scot
Chief Scientific Officer
2024-08-01 17:45:4643,310
15
43,325Form 4
Hodges Philip
Director
2024-09-30 18:35:3134,900
0
34,900Form 4
SAYARE MITCHEL
Director
2024-09-30 18:35:0534,900
0
34,900Form 4
Schafer Klaus
Director
2024-09-30 18:34:4134,900
0
34,900Form 4
GILL JOHN
Director
2024-09-30 18:34:1634,900
0
34,900Form 4
Jorkasky Diane
Director
2024-09-30 18:33:4234,900
0
34,900Form 4
Sohn Catherine A.
Director
2024-09-30 18:33:1834,900
0
34,900Form 4
Pisano Wayne
Director
2024-09-30 18:36:0034,900
0
34,900Form 4
Schellhammer Wayne A
Former Director
Director
2007-08-07 20:05:0822,500
0
22,500Form 4
Berger Edward B
Former Director
Director
2007-08-09 17:08:5222,500
0
22,500Form 4
PAPPAJOHN JOHN
Director
2011-06-27 19:47:2220,000
0
20,000Form 4
Tasker Sybil
Chief Medical Officer
2019-06-19 16:01:2920,000
0
20,000Form 4
Brown William Michael
Chief Financial Officer
2021-08-06 19:01:0717,721
0
17,721Form 4
Jordt Raymond M
Chief Business Officer
2024-08-01 17:43:3314,660
0
14,660Form 4
MARKISON BRIAN A
Director
2015-01-05 21:30:4912,241
0
12,241Form 4
Shutterly Andrew
Acting Chief Financial Officer
2024-08-01 17:47:5911,372
0
11,372Form 4
Fusco Joan
SVP, Operations
2010-05-17 17:34:160
10,000
10,000Form 4/A
McCleary Joel
Director
2015-01-05 21:28:305,061
0
5,061Form 4
MPM BIOVENTURES III LLC
MPM BIOVENTURES III PARALLEL FUND L.P.
MPM BIOVENTURES III GMBH & CO. Beteiligungs KG
MPM BIOVENTURES III L.P.
MPM BIOVENTURES III GP L.P.
MPM BIOVENTURES III-QP L.P.
MPM Asset Management Investors 2004 BVIII LLC
10% Owner
2016-03-29 20:53:060
0
0Form 13D